SEC Form 4 · accession 0001209191-17-066235
GENOMIC HEALTH INC · GHDX
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Laura Leber
Officer — Chief Communication Officer
Period of report
Dec 14, 2017
Accepted (ET)
Dec 18, 2017 · 7:52 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001131324
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Dec 14, 2017 | M | 12,000 | $21.52 | A | 27,754 | D | |
| Common StockF2,F3,F1 | Dec 14, 2017 | S | 12,000 | $32.00 | D | 15,754 | D | |
| Common StockF1 | Dec 15, 2017 | M | 9,000 | $17.33 | A | 24,754 | D | |
| Common StockF2,F3,F1 | Dec 15, 2017 | S | 9,000 | $35.00 | D | 15,754 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Employee Stock Option (right to buy)F4 | $21.52 | Dec 14, 2017 | M | 12,000 | D | — | Apr 30, 2018 | Common Stock | 0 | 0 | D |
| Employee Stock Option (right to buy)F5 | $17.33 | Dec 15, 2017 | M | 9,000 | D | — | Dec 4, 2018 | Common Stock | 0 | 0 | D |
Explanation of responses
- F1Includes an aggregate of 11,010 shares of common stock issuable pursuant to previously reported restricted stock units that have not vested.
- F2These sales of common stock were effected pursuant to Rule 10b5-1 sales plan adopted by the reporting person on May 11, 2017.
- F3Represents actual sale price.
- F4The option became exercisable as to 25% of the shares on April 30, 2009, and became exercisable as to 1/48th of the shares each full month thereafter.
- F5The option became exercisable as to 25% of the shares on December 4, 2009, and became exercisable as to 1/48th of the shares each full month thereafter.